Osmitrol Injection Structural Formula (Image 01)
Osmitrol Injection, Solution
Product Images NDC 0338-0353
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Osmitrol (NDC 0338-0353). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Baxter Healthcare Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Osmitrol Injection Representative Container Label Ndc 0338-0351-04 (Image 02)
Image 03
This text seems to be a label of a medicine container. The product is a 1000 ML saline solution containing 5% Osmotrol and Mannitol injection. It is available in a Viaflex container. The label also contains a code that could be a primary bar code for the product.*
Image 04
This is a description of a medication called OSMITROL, specifically the 10% Mannitol Injection USP, in a 500mL container. The medication is to be adjusted to a pH of 7.0 using either sodium hydroxide or hydrochloric acid. The solution is clear and should be inspected before use. This should be administered intravenously under the direction of a physician, with caution about using it in conjunction with certain other drugs. It is made by Baxter Healthcare Corporation in Deerfield, Illinois, and should be stored between 25°C/77°F in a VIaflex container until ready to use.*
Image 05
This is a description of a medical product in a container labeled as "VIAFLEX CONTAINER" with the product code "2D5613Q 24-500 ML". The product is a type of injection that contains 10% OSMITROL and 10% MANNITOL, both USP. The label contains a secondary bar code with an expiration date indicated as "YYMMOO" and a primary bar code with a lot number indicated as "XXXXX". There is an additional bar code at the bottom labeled as "50303380353038" with no information on its meaning or use.*
Image 06
This is a description of a medical injection package containing 15% OSMITROL. The injection is made up of 15 g MANNITOL USP whose pH is adjusted with sodium hydroxide or hydrochloric acid to pH 5.0. The injection comes in a 500 ml single-dose container that is sterile and nonpyrogenic. It functions as an osmotic diuretic and must be administered intravenously by a physician using a filter type set as directed. The directions for use and precautions are printed on the package. It should be stored in a moisture barrier overwrap at a temperature of 25°C until ready to use, and excess heat should be avoided. Baxter OSMITROL VIAFLEX D PL 146 are the registered trademarks of Baxter International Inc.*
Image 07
This is a description of a drug container with a volume of 24-500 milliliters. The container is referred to as a VIAFLEX container and is being used to hold either 5% OSMITROL INJECTION or 5% MANNITOL INJECTION that is compliant with the USP. There are primary and secondary bar codes located on the container. The primary bar code includes a LOT number along with a set of X's, while the secondary bar code includes a set of numbers and letters that indicate expiration information.*
Image 08
This is a description of a medical product called "20% OSMITROL Injection". It is a mannitol solution, which is a type of osmotic diuretic used to treat conditions such as brain swelling or kidney failure. The product is sterile and packaged in a single-dose, nonpyrogenic container. It is administered intravenously by a physician using a filter-type set, and caution must be exercised to avoid potential vein damage. The text provides specific instructions for handling and storage, including warnings against using the product with certain other medications or in certain medical conditions. Contact information is provided for Baxter, the manufacturer of the product, for more information.*
Image 09
This is a description of a medication with the brand name 2D5632Q in a 36-250 ML VIAFLEX container. The medication is a 20% Mannitol injection (also known as 20% Osmitrol Injection, USP) and is intended for medical use. There are secondary and primary barcodes labeled with lot and expiration dates respectively.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
